OPGX — Optigenex Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $4.25m
- $0.69m
Annual income statement for Optigenex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | 2007 December 31st | 2009 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | PRESS |
| Standards: | USG | USG | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0.301 | 0.466 | 0.688 |
| Cost of Revenue | |||
| Gross Profit | -1.22 | -0.103 | 0.5 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | -2.33 | 0.566 | 1.01 |
| Operating Profit | 2.63 | -0.1 | -0.319 |
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | -7.36 | -2.9 | -0.702 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -7.36 | -2.9 | -0.702 |
| Net Income Before Extraordinary Items | |||
| Net Income | -7.36 | -2.9 | -0.702 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | -7.36 | -2.9 | -0.702 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -194,884 | -36,983 | -1,554 |
| Dividends per Share |